Charles Puza, a board-certified dermatologist in both medical and cosmetic dermatology at New York Dermatology Group, is seeing more patients coming in with concerns about skin changes after starting GLP-1 medications
The development of next-generation oral GLP-1 agents with improved bioavailability enabling the higher systemic drug exposures needed to match injectable efficacy is the key technical milestone that will determine how much of the injectable market oral formulations can ultimately capture
This challenge is why some scientists question whether oral GLP-1 drugs can be as potent as injectables, Cavender says
While glutathione injections may offer quicker and more significant skin-lightening effects, they come with higher costs
Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB
Lean PMOS can still involve androgens, irregular cycles, thyroid issues, stress physiology, inflammation, or nutrient problems